Use of Generics-A Critical Cost Containment Measure for All Healthcare Professionals in Europe?
about
Comprehensive taxonomy and worldwide trends in pharmaceutical policies in relation to country income status.Can authorities appreciably enhance the prescribing of oral generic risperidone to conserve resources? Findings from across Europe and their implications.A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study.Knowledge and perceptions of physicians from private medical centres towards generic medicines: a nationwide survey from Malaysia.Combination of prescribing restrictions and policies to engineer low prices to reduce reimbursement costs.The potential influence of various initiatives to improve rational prescribing for proton pump inhibitors and statins in Belgium.Reforms and initiatives in Scotland in recent years to encourage the prescribing of generic drugs, their influence and implications for other countries.Impact of delisting ARBs, apart from losartan, on ARB utilisation patterns in Denmark: implications for other countries.Ongoing measures to enhance the efficiency of prescribing of proton pump inhibitors and statins in The Netherlands: influence and future implications.Possible ways to enhance renin-angiotensin prescribing efficiency: Republic of Serbia as a case history?Statin prescribing among hypertensive patients in southwest Nigeria: findings and implications for the future.Drug Pricing in South Korea.Generic medicines: solutions for a sustainable drug market?Ongoing initiatives in the Republic of Srpska to enhance prescribing efficiency: influence and future directions.Initiatives to improve prescribing efficiency for drugs to treat Parkinson's disease in Croatia: influence and future directions.Influence of patient co-payments on atypical antipsychotic choice in Poland: implications once generic atypicals are available.Influence of lifting prescribing restrictions for losartan on subsequent sartan utilization patterns in Austria: implications for other countries.Multilevel analysis of the influence of patients' and general practitioners' characteristics on patented versus multiple-sourced statin prescribing in France.You Can't Always Get What You Want: The Influence of Choice on Nocebo and Placebo Responding.Are specific initiatives required to enhance prescribing of generic atypical antipsychotics in Scotland?: International implications.A New Reimbursement System for Innovative Pharmaceuticals Combining Value-Based and Free Market PricingImperative to consider multiple initiatives to maximize prescribing efficiency from generic availability: case history from Abu Dhabi
P2860
Q33730376-C9B785AA-8624-4DDA-871F-AFAF2755CD70Q33816182-8440E266-58E9-4412-AF0E-8EA10B5743AEQ34536861-9BD0111F-CAEE-47DB-B3B6-FA037D839B42Q35224195-F613BCB4-FEE5-478C-BF13-8870D46513E8Q37847158-578C8198-DB6F-459E-81C2-16ABEA710633Q38080920-F60DBB3F-5221-49EA-B0D9-96F9F79494C5Q38131544-79ABD1AA-2120-4C69-AA69-161C6FC269B7Q38150706-86D3658B-10ED-4FD7-BE41-3381079E91B6Q38162866-EDD46F08-B9E9-442C-A6C9-439489222D27Q38162867-102D8DDC-311F-4E7C-AD87-173A9D302A2CQ38878608-B88F21CF-7A12-419E-8F48-BD775FF69963Q39110814-885DD2B1-7EA6-47B8-B320-DD227917F48CQ39386312-6EE06D8F-7FB4-47CD-8949-371AA5C1AA54Q39513393-DA20587B-FE63-44D0-9B0E-3938577F0CB2Q39583380-70D09497-9ACD-4CB4-B685-2FB9A6FADA6DQ42687717-A293A157-536E-41D8-A10B-8B8AAD36DE51Q43918109-827D7F34-800B-4154-B190-A92DF3A0506AQ44132532-67244752-8FF1-42EC-9B48-98D58AB54F8EQ47595448-3C74E916-011F-425E-A04B-3032202BCCF8Q51202982-CF824687-3C2A-4562-9E32-AED6D9774E3FQ56828539-318EAA88-D1B5-462E-A242-4864639E732BQ56828549-6FEA1ECD-3A73-4E8C-871E-08BFED108DA4
P2860
Use of Generics-A Critical Cost Containment Measure for All Healthcare Professionals in Europe?
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Use of Generics-A Critical Cos ...... hcare Professionals in Europe?
@ast
Use of Generics-A Critical Cos ...... hcare Professionals in Europe?
@en
type
label
Use of Generics-A Critical Cos ...... hcare Professionals in Europe?
@ast
Use of Generics-A Critical Cos ...... hcare Professionals in Europe?
@en
prefLabel
Use of Generics-A Critical Cos ...... hcare Professionals in Europe?
@ast
Use of Generics-A Critical Cos ...... hcare Professionals in Europe?
@en
P2093
P2860
P356
P1433
P1476
Use of Generics-A Critical Cos ...... hcare Professionals in Europe?
@en
P2093
Bjorn Wettermark
Brian Godman
Catherine Sermet
Corinne Zara
F Cankat Tulunay
Iain Bishop
Inês Teixeira
Kamila Wendykowska
Kristina Garuolienè
Marija Kalaba
P2860
P304
P356
10.3390/PH3082470
P577
2010-08-05T00:00:00Z